Sequenom (SQNM) Rises as CMM Unit Inks Several Int'l Agreements
Tweet
Share
E-mailGet Alerts SQNM Hot Sheet
Join SI Premium – FREE
Sequenom, Inc. (Nasdaq: SQNM) is popping higher in early trading following news earlier that its wholly-owned subsidiary, the Sequenom Center for Molecular Medicine (Sequenom CMM), has completed several international distribution agreements that will expand access to the MaterniT21 PLUS testing service outside the United States.
Shares of Sequenom are up 3.9 percent ahead of the bell Tuesday.
Shares of Sequenom are up 3.9 percent ahead of the bell Tuesday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup set to join top banks in Anthropic IPO - Bloomberg
- 30-year mortgage rate dips to 6.65%, second weekly decline
- Nvidia plans China chip shipments with export-compliant AI processor - The Information
Create E-mail Alert Related Categories
Momentum Movers, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
